Pai et al. reported that chrysin led to a marked improvement in liver steatosis, and they attributed this improvement to a decrease in SREBP-1c expression and an increase in PPAR-α expression, which resulted in a significant reduction in free fatty acids, triglycerides, and cholesterol [20]. The gene discussed is SREBF1; the disease is fatty liver disease.